ZYLLT

This brand name is authorized in Albania, Austria, Estonia, Ireland, Italy, Lithuania, Poland, Romania

Active ingredients

The drug ZYLLT contains one active pharmaceutical ingredient (API):

1 Clopidogrel UNII A74586SNO7 - CLOPIDOGREL

Clopidogrel is a prodrug, one of whose metabolites is an inhibitor of platelet aggregation. Clopidogrel must be metabolised by CYP450 enzymes to produce the active metabolite that inhibits platelet aggregation. Read about Clopidogrel

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ZYLLT Film-coated tablet	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
B01AC04	Clopidogrel	B Blood and blood forming organs → B01 Antithrombotic agents → B01A Antithrombotic agents → B01AC Platelet aggregation inhibitors excl. heparin
Discover more medicines within B01AC04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AL	Fondi i Sigurimit të Detyrueshëm të Kujdesit Shëndetësor	Identifier(s): 410/73
Country: EE	Ravimiamet	Identifier(s): 1437443, 1437454, 1437465, 1437476, 1437487, 1437498, 1437500, 1437511, 1437522, 1437533
Country: IT	Agenzia del Farmaco	Identifier(s): 042361030
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1005187, 1050351, 1050352, 1050354, 1050355, 1050356, 1050357, 1050358, 1050359, 1050360
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100131390
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W54626001, W54626002, W54626003, W54626004, W54626005, W54626006, W54626007, W54626008, W54626009, W54626010